The groundbreaking clinical trials happening here at the Huntsman Cancer Institute are saving lives, and it is made possible in part by people like you—our donors. For Samuel Cheshier, MD...
Each month, we’d like to highlight some current work at Huntsman Cancer Institute. See how a potential new immunotherapy for breast cancer is being developed, learn about research being done...
The Lymphoma Research Foundation selected Daniel Ermann, MD, for the highly competitive Lymphoma Scientific Research Mentoring Program, class of 2023. The foundation awards a career development grant of $10,000 to...
Professionals at Huntsman Cancer Institute work with young patients and their families. Yelena Wu, PhD, describes how her team is continually working, collaborating, and innovating to move beyond typical practices.
A medication using venom from a poisonous sea snail is currently in use at Huntsman Cancer Institute to help with pain relief. Researchers are studying the venom's components to see...
This time of year, many people think about their families and loved ones. For those who know someone with cancer, the season can be overwhelming. In this latest Letter of...
Huntsman Cancer Institute's Doug Fair, MD, and Center for HOPE team earned 2022 Cancer Community (C2) awards for their outstanding work and contributions to cancer research and patient care. Former...
Professor Martin McMahon has dedicated his career to making an impact on cancer through research and mentoring trainees in his lab. The native Scot recently returned to his homeland to...
A brisk walk for 20 minutes a day may not sound like much, but it could make a big difference for colorectal cancer patients. Regular physical activity reduces inflammation by...
Michael Allen Pulsipher, MD, chief of Pediatric Hematology and Oncology at Huntsman Cancer Institute, shares a Letter of Hope. He explains how his work, and that of other oncologists and...
Researchers at Huntsman Cancer Institute have solved a long-standing mystery about how a cancer-promoting protein causes drug-resistant tumors to grow. They hope the discovery leads to more effective cancer drugs...
Following her diagnosis with a neuroendocrine tumor (NET), Leslie Bangeter took time to grieve—then started planning a fundraiser for this rare cancer. Motivated by her doctor, Heloisa Soares, MD, PhD...
Huntsman Cancer Institute celebrates the addition of two endowed chair holders and a fellowship, as well as the renewal of two esteemed endowed chairs. CEO Mary Beckerle, PhD, congratulates distinguished...
Patients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less cancer family history information available to them. In addition, existing health records are...
